Résultats de la recherche - Schettini, Francesco
- Résultat(s) 1 - 20 résultats de 23
- Aller à la page suivante
-
1
-
2
-
3
-
4
BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives? par Bouchè, Victoria, Aldegheri, Giovanni, Donofrio, Carmine Antonio, Fioravanti, Antonio, Roberts-Thomson, Samuel, Fox, Stephen B., Schettini, Francesco, Generali, Daniele
Publié 2021Texte -
5
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors par Schettini, Francesco, De Santo, Irene, Rea, Carmen G., De Placido, Pietro, Formisano, Luigi, Giuliano, Mario, Arpino, Grazia, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Del Mastro, Lucia
Publié 2018Texte -
6
Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis par De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia
Publié 2017Texte -
7
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series par Schettini, Francesco, Santo, Irene De, Rea, Carmen G., Viggiani, Martina, Buono, Giuseppe, Angelis, Carmine De, Cardalesi, Cinzia, Lauria, Rossella, Giuliano, Mario, Forestieri, Valeria, Thomas, Guglielmo, Maione, Pierfrancesco, Limite, Gennaro, Accurso, Antonello, Malorni, Luca, Placido, Sabino De, Arpino, Grazia
Publié 2020Texte -
8
Frequency and spectrum of PIK3CA somatic mutations in breast cancer par Martínez-Sáez, Olga, Chic, Nuria, Pascual, Tomás, Adamo, Barbara, Vidal, Maria, González-Farré, Blanca, Sanfeliu, Esther, Schettini, Francesco, Conte, Benedetta, Brasó-Maristany, Fara, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Ana Belén, Martinez, Antonio, Muñoz, Montserrat, Prat, Aleix
Publié 2020Texte -
9
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study par Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., Generali, Daniele
Publié 2020Texte -
10
Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study par Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, Pensabene, Matilde, De Laurentiis, Michelino, Augustin, Livia Silvia Adriana, Amore, Alfonso, D'Aiuto, Massimiliano, Tortoriello, Raffaele, Accurso, Antonello, Cavalcanti, Ernesta, Botti, Gerardo, Montella, Maurizio, De Placido, Sabino, Arpino, Grazia
Publié 2017Texte -
11
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified accordin... par Carbognin, Luisa, Simbolo, Michele, Caliò, Anna, Vicentini, Caterina, Delfino, Pietro, Sperduti, Isabella, Fassan, Matteo, Schettini, Francesco, Dieci, Maria Vittoria, Griguolo, Gaia, Pilotto, Sara, Fiorio, Elena, Arpino, Grazia, Guarneri, Valentina, De Placido, Sabino, Conte, Pierfranco, Manfrin, Erminia, Brunelli, Matteo, Scambia, Giovanni, Scarpa, Aldo, Tortora, Giampaolo, Bria, Emilio
Publié 2020Texte -
12
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis par Schettini, Francesco, Giudici, Fabiola, Giuliano, Mario, Cristofanilli, Massimo, Arpino, Grazia, Del Mastro, Lucia, Puglisi, Fabio, De Placido, Sabino, Paris, Ida, De Placido, Pietro, Venturini, Sergio, De Laurentis, Michelino, Conte, PierFranco, Juric, Dejan, Llombart-Cussac, Antonio, Pusztai, Lajos, Prat, Aleix, Jerusalem, Guy, Di Leo, Angelo, Generali, Daniele
Publié 2020Texte -
13
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis par Schettini, Francesco, Giuliano, Mario, Giudici, Fabiola, Conte, Benedetta, De Placido, Pietro, Venturini, Sergio, Rognoni, Carla, Di Leo, Angelo, Locci, Mariavittoria, Jerusalem, Guy, Del Mastro, Lucia, Puglisi, Fabio, Conte, PierFranco, De Laurentiis, Michelino, Pusztai, Lajos, Rimawi, Mothaffar F., Schiff, Rachel, Arpino, Grazia, De Placido, Sabino, Prat, Aleix, Generali, Daniele
Publié 2021Texte -
14
Gene expression profiles of breast cancer metastasis according to organ site par Brasó‐Maristany, Fara, Paré, Laia, Chic, Nuria, Martínez‐Sáez, Olga, Pascual, Tomás, Mallafré‐Larrosa, Meritxell, Schettini, Francesco, González‐Farré, Blanca, Sanfeliu, Esther, Martínez, Débora, Galván, Patricia, Barnadas, Esther, Salinas, Belinda, Tolosa, Pablo, Ciruelos, Eva, Carcelero, Esther, Guillén, Cecilia, Adamo, Barbara, Moreno, Reinaldo, Vidal, Maria, Muñoz, Montserrat, Prat, Aleix
Publié 2021Texte -
15
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study par Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, De Laurentiis, Michelino, De Placido, Pietro, Rea, Carmen Giusy, Pacilio, Carmen, Esposito, Emanuela, Grimaldi, Maria, Nocerino, Flavia, Porciello, Giuseppe, Giudice, Aldo, Amore, Alfonso, Minopoli, Anita, Botti, Gerardo, De Placido, Sabino, Trivedi, Meghana V., Arpino, Grazia
Publié 2020Texte -
16
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy par Chic, Nuria, Schettini, Francesco, Brasó-Maristany, Fara, Sanfeliu, Esther, Adamo, Barbara, Vidal, Maria, Martínez, Débora, Galván, Patricia, González-Farré, Blanca, Cortés, Javier, Gavilá, Joaquín, Saura, Cristina, Oliveira, Mafalda, Pernas, Sònia, Martínez-Sáez, Olga, Soberino, Jesús, Ciruelos, Eva, Carey, Lisa A., Muñoz, Montserrat, Perou, Charles M., Pascual, Tomás, Bellet, Meritxell, Prat, Aleix
Publié 2021Texte -
17
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy par Martínez-Sáez, Olga, Pascual, Tomás, Brasó-Maristany, Fara, Chic, Nuria, González-Farré, Blanca, Sanfeliu, Esther, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Anna Belén, Schettini, Francesco, Conte, Benedetta, Vidal, Maria, Adamo, Barbara, Martínez, Antoni, Muñoz, Montserrat, Moreno, Reinaldo, Villagrasa, Patricia, Salvador, Fernando, Ciruelos, Eva M., Faull, Iris, Odegaard, Justin I., Prat, Aleix
Publié 2021Texte -
18
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial par Schettini, Francesco, Corona, Silvia Paola, Giudici, Fabiola, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Ziglioli, Nicoletta, Aguggini, Sergio, Azzini, Carlo, Barbieri, Giuseppina, Cervoni, Valeria, Cappelletti, Maria Rosa, Molteni, Alfredo, Lazzari, Maria Chiara, Ferrero, Giuseppina, Ungari, Marco, Marasco, Elena, Bruson, Alice, Xumerle, Luciano, Zago, Elisa, Cerra, Davide, Loddo, Marco, Williams, Gareth H., Paris, Ida, Scambia, Giovanni, Generali, Daniele
Publié 2021Texte -
19
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer par Schettini, Francesco, Chic, Nuria, Brasó-Maristany, Fara, Paré, Laia, Pascual, Tomás, Conte, Benedetta, Martínez-Sáez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther, Fernández-Martinez, Aranzazu, González-Farre, Blanca, Sanfeliu, Esther, Cejalvo, Juan Miguel, Perrone, Giuseppe, Sabarese, Giovanna, Zalfa, Francesca, Peg, Vicente, Fasani, Roberta, Villagrasa, Patricia, Gavilá, Joaquín, Barrios, Carlos H., Lluch, Ana, Martín, Miguel, Locci, Mariavittoria, De Placido, Sabino, Prat, Aleix
Publié 2021Texte -
20
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer par Prat, Aleix, Guarneri, Valentina, Pascual, Tomás, Brasó-Maristany, Fara, Sanfeliu, Esther, Paré, Laia, Schettini, Francesco, Martínez, Débora, Jares, Pedro, Griguolo, Gaia, Dieci, Maria Vittoria, Cortés, Javier, Llombart-Cussac, Antonio, Conte, Benedetta, Marín-Aguilera, Mercedes, Chic, Nuria, Puig-Butillé, Joan Anton, Martínez, Antonio, Galván, Patricia, Tsai, Yi-Hsuan, González-Farré, Blanca, Mira, Aurea, Vivancos, Ana, Villagrasa, Patricia, Parker, Joel S., Conte, Pierfranco, Perou, Charles M.
Publié 2022Texte